Frontiers | Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
GeneCopoeia: IFN alpha signaling pathway
The Overview of Interferon-CUSABIO
Frontiers | Type-I Interferons in Alzheimer's Disease and Other Tauopathies
How cancer cells make and respond to interferon-I: Trends in Cancer
Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram
Interferons Research Area: R&D Systems
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
An Atomic Model of the Interferon-β Enhanceosome: Cell
Frontiers | The Role of Interferons in Inflammation and Inflammasome Activation
Interferons: role in cancer therapy | Immunotherapy
Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram
IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways: Cell
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
Decoding type I and III interferon signalling during viral infection | Nature Microbiology
